Back to search

Article

Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID®) with Concomitant Medications in Real-World Clinical Settings

2024-04-18

Abstract excerpt

<title>Abstract</title> <p>Purpose This research article delves into the battle against the COVID-19 pandemic, focusing on the efficacy and safety of the combination of nirmatrelvir with ritonavir, found in the pharmaceutical product Paxlovid®. The study aims to analyze the potential interactions of commonly prescribed medicinal products with Paxlovid®, shedding light on its utilization in specific medical field...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8b22fde5-4645-5fce-b135-2d5eb359fb85
DOI
10.21203/rs.3.rs-4265272/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluating Drug Interaction Risks: Nirmatrelvir &amp; Ritonavir Combination (PAXLOVID®) with Concomitant Medications in Real-World Clinical SettingsDOI 10.21203/rs.3.rs-4265272/v1
Evaluating Nirmatrelvir-Ritonavir (Paxlovid®) in Outpatient COVID-19 Treatment: Safety, Tolerability, and Adherence Insights from Primary Healthcare ClinicsSemantic proximity
Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational study.Semantic proximity
Molnupiravir Compared to Nirmatrelvir/Ritonavir for COVID-19 in High-Risk Patients with Haematological Malignancy in Europe. A Matched-Paired Analysis from the Epicovideha RegistrySemantic proximity
Adverse drug reactions associated with the use of biological agentsSemantic proximity
Drug-Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study.Semantic proximity
Viral target and metabolism‐based rationale for combined use of recently authorized small molecule COVID‐19 medicines: Molnupiravir, nirmatrelvir, and remdesivirSemantic proximity
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for TivozanibSemantic proximity
Analysis of Patient Access to Orphan Drugs in TurkeySemantic proximity
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Semantic proximity
Research Progress on High-Risk Drugs for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Insights from Adverse Drug Reaction Database MiningSemantic proximity
Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugsSemantic proximity
The IDentif.AI 2.0 Pandemic Readiness Platform: Rapid Prioritization of Optimized COVID-19 Combination Therapy RegimensSemantic proximity
Select a neighboring publication to make it the new centre.